303 related articles for article (PubMed ID: 18649639)
21. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
[TBL] [Abstract][Full Text] [Related]
22. Tracheal intubation: optimal conditions, vocal cord damage, and allergy.
Donati F; Plaud B
Can J Anaesth; 2008 Oct; 55(10):663-9. PubMed ID: 18835963
[No Abstract] [Full Text] [Related]
23. Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex.
Carron M; Parotto E; Ori C
Minerva Anestesiol; 2012 Jan; 78(1):112-3. PubMed ID: 22237790
[No Abstract] [Full Text] [Related]
24. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
Dahaba AA; Bornemann H; Hopfgartner E; Ohran M; Kocher K; Liebmann M; Wilfinger G; Metzler H
Br J Anaesth; 2012 Apr; 108(4):602-6. PubMed ID: 22315331
[TBL] [Abstract][Full Text] [Related]
25. Development and potential clinical impairment of ultra-short-acting neuromuscular blocking agents.
Lien CA
Br J Anaesth; 2011 Dec; 107 Suppl 1():i60-71. PubMed ID: 22156271
[TBL] [Abstract][Full Text] [Related]
26. [Muscle relaxants and neuromuscular monitoring - Introduction for a safe clinical application].
Döcker D; Walther A
Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 May; 47(5):296-305; quiz 306. PubMed ID: 22628025
[TBL] [Abstract][Full Text] [Related]
27. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
de Menezes CC; Peceguini LA; Silva ED; Simões CM
Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
[TBL] [Abstract][Full Text] [Related]
28. Intubating conditions after pipecuronium bromide: the influence of dose and time.
Azad SS; Larijani GE; Bartkowski R; Seltzer JL; Weinberger M; Marr A; Goldberg ME
J Clin Anesth; 1991; 3(3):202-6. PubMed ID: 1652264
[TBL] [Abstract][Full Text] [Related]
29. A comparison of neuromuscular effects, tracheal intubating conditions, and reversibility of rapacuronium versus mivacurium in female patients.
Vanacker BF; Geerts E; Coppens S; van Iersel M
Anesth Analg; 2002 Apr; 94(4):876-8, table of contents. PubMed ID: 11916789
[TBL] [Abstract][Full Text] [Related]
30. Muscle relaxants in paediatric day case surgery.
Meakin GH
Eur J Anaesthesiol Suppl; 2001; 23():47-52. PubMed ID: 11766247
[TBL] [Abstract][Full Text] [Related]
31. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
32. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacology of neuromuscular blocking agents.
Fisher DM
Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710
[TBL] [Abstract][Full Text] [Related]
34. Rapacuronium: first experience in clinical practice.
Bartkowski RR; Witkowski TA
Eur J Anaesthesiol Suppl; 2001; 23():90-3. PubMed ID: 11766254
[TBL] [Abstract][Full Text] [Related]
35. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
Nicholson WT; Sprung J; Jankowski CJ
Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
[TBL] [Abstract][Full Text] [Related]
36. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study.
Grosse-Sundrup M; Henneman JP; Sandberg WS; Bateman BT; Uribe JV; Nguyen NT; Ehrenfeld JM; Martinez EA; Kurth T; Eikermann M
BMJ; 2012 Oct; 345():e6329. PubMed ID: 23077290
[TBL] [Abstract][Full Text] [Related]
37. Muscle relaxant use for tracheal intubation in pediatric anaesthesia: a survey of clinical practice in Germany.
Nauheimer D; Fink H; Fuchs-Buder T; Geldner G; Hofmockel R; Ulm K; Wallek B; Blobner M
Paediatr Anaesth; 2009 Mar; 19(3):225-31. PubMed ID: 19175884
[TBL] [Abstract][Full Text] [Related]
38. Neuromuscular blockade.
Neigh JL
Surg Clin North Am; 1975 Aug; 55(4):837-50. PubMed ID: 241125
[No Abstract] [Full Text] [Related]
39. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
Martin-Flores M; Paré MD; Campoy L; Gleed RD
Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
[TBL] [Abstract][Full Text] [Related]
40. Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting).
Fuchs-Buder T; Mencke T
Eur J Anaesthesiol Suppl; 2001; 23():53-9. PubMed ID: 11766248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
